Drugs / Neu-120
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00607451 | Mar 2008 → Aug 2016 | drug-induced dyskinesia | Neurim Pharmaceuticals Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neu-120 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00607451 ↗ |
| Route | Oral | “orally administered Neu-120” NCT00607451 ↗ |